Sema4 (NASDAQ:SMFR – Get Rating) and DCC (OTCMKTS:DCCPF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations. Analyst Recommendations This is a summary of recent ratings for Sema4 and […]